MUC1: The First Respiratory Mucin with an Anti-Inflammatory Function
AbstractMUC1 is a membrane-bound mucin expressed on the apical surfaces of most mucosal epithelial cells. In normal lung epithelia, MUC1 is a binding site for Pseudomonas aeruginosa, an opportunistic human pathogen of great clinical importance. It has now been established that MUC1 also serves an anti-inflammatory role in the airways that is initiated late in the course of a bacterial infection and is mediated through inhibition of Toll-like receptor (TLR) signaling. MUC1 expression was initially shown to interfere with TLR5 signaling in response to P. aeruginosa flagellin, but has since been extended to other TLRs. These new findings point to an immunomodulatory role for MUC1 during P. aeruginosa lung infection, particularly during the resolution phase of inflammation. This review briefly summarizes the recent characterization of MUC1’s anti-inflammatory properties in both the respiratory tract and extrapulmonary tissues. View Full-Text
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Kato, K.; Lillehoj, E.P.; Lu, W.; Kim, K.C. MUC1: The First Respiratory Mucin with an Anti-Inflammatory Function. J. Clin. Med. 2017, 6, 110.
Kato K, Lillehoj EP, Lu W, Kim KC. MUC1: The First Respiratory Mucin with an Anti-Inflammatory Function. Journal of Clinical Medicine. 2017; 6(12):110.Chicago/Turabian Style
Kato, Kosuke; Lillehoj, Erik P.; Lu, Wenju; Kim, Kwang Chul. 2017. "MUC1: The First Respiratory Mucin with an Anti-Inflammatory Function." J. Clin. Med. 6, no. 12: 110.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.